EPC syntheses and structure-activity relationships of hypoglycaemic semicyclic amidines

Citation
S. Hartmann et al., EPC syntheses and structure-activity relationships of hypoglycaemic semicyclic amidines, EUR J MED C, 35(4), 2000, pp. 377-392
Citations number
39
Categorie Soggetti
Chemistry & Analysis
Journal title
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
ISSN journal
02235234 → ACNP
Volume
35
Issue
4
Year of publication
2000
Pages
377 - 392
Database
ISI
SICI code
0223-5234(200004)35:4<377:ESASRO>2.0.ZU;2-Y
Abstract
A series of homochiral sterically hindered mono- and bicyclic amidines was prepared as hypoglycaemic agents by lethargic reaction of O-methylcaprolact im and 3-ethoxy-2-azabicyclo[2.2.2]oct-2-ene, respectively, with homochiral cis-2-substituted cyclopentane amines provided by asymmetrical reductive a mination of racemic 2-substituted cyclopentanones. All compounds, except th e cyclohexylmethylisoqoinuclidone derivative which inhibited secretion at 1 00 mu M, significantly stimulated insulin secretion 2-8-fold at 10 mu M and 100 mu M in INS-1 cells. The most potent activator was the 2-cyclopentyl-s ubstituted caprolactam derivative 5e. The stimulatory effects on secretion increased with rising steric hindrance of both the amidine alpha-carbon and the bicyclic amidine moiety itself. Enantiomeric discrimination was observ ed for the 2-[(cis-2-bulkysubstituted cyclopentyl)imino]hexahydroazepine ha lides 5e and 5f and for the 3-[(cis-2-substituted cyclopentyl)imino]-2-azab icyclo[2.2.2]octane halides 6a and 6c. The amidines depolarized INS-1 cells and generated action potentials, accompanied by a decrease of membrane con ductance. Simultaneously [Ca2+](i) increased, probably due to Ca2+-entry th rough voltage-dependent Ca2+-channels. At high concentrations, where inhibi tion of secretion was observed, [Ca2+](i) still rose upon application of th e amidines, indicating an additional inhibitory pathway downstream to the e levation of [Ca2+](i). Even at high concentrations (100 mu M), the amidines had no toxic effects on insulin secreting INS-1 cells. (C) 2000 Editions s cientifiques et medicales Elsevier SAS.